Helsinn sued Gland under the Hatch-Waxman Act over Gland's ANDA No. 217374 for generic fosnetupitant/palonosetron IV product, asserting ten patents including U.S. 10,828,297; the action was also cited in some sources as 2:22-cv-04635. It was resolved by consent judgment and dismissal order in January 2023, with Gland admitting technical infringement under 35 U.S.C. § 271(e)(2)(A) and enjoined from marketing the ANDA product until a redacted date; Gland's invalidity/non-infringement counterclaims were not adjudicated.

Case overview & background

Plain-language overview of the case: parties, accused product, patents at issue, and why the suit matters.

Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).

Key legal developments & outcome

Major rulings, motions, claim construction, settlements, and the present posture or final disposition.

Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).

Plaintiff representatives

Counsel of record for the plaintiff(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).

Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).

Defendant representatives

Counsel of record for the defendant(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).

Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).

Record id: 10828297-3-22-cv-04635 · edit in Admin